No Increased Risk of Pancreatitis The analysis found no evidence that GLP-1 receptor agonist use increased the risk of developing acute pancreatitis
The drug, the concentration in mg/mL, the total volume in the vial, your prescribed dose and how it is to be measured
Injectable GLP-1 agonists have gained popularity as a breakthrough solution for individuals struggling to shed excess weight
Someone who believes they are injecting 250mcg may actually be receiving 150mcg or 400mcg
Sensitivity analyses incorporated three validated pharmacovigilance methods: proportional reporting ratio (PRR), information component (IC), and empirical Bayes geometric mean (EBGM)
Along with that, the plan also comes with one-on-one telehealth visits, messaging with weight loss doctors, an online community and an insurance care team, who ensures your medication is covered